CN104257781A - External preparation for treating vitiligo - Google Patents

External preparation for treating vitiligo Download PDF

Info

Publication number
CN104257781A
CN104257781A CN201410504899.0A CN201410504899A CN104257781A CN 104257781 A CN104257781 A CN 104257781A CN 201410504899 A CN201410504899 A CN 201410504899A CN 104257781 A CN104257781 A CN 104257781A
Authority
CN
China
Prior art keywords
radix
external preparation
treatment
fructus
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410504899.0A
Other languages
Chinese (zh)
Inventor
王生学
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410504899.0A priority Critical patent/CN104257781A/en
Publication of CN104257781A publication Critical patent/CN104257781A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/638—Ligustrum, e.g. Chinese privet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716—Clematis (leather flower)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating vitiligo and belongs to the field of traditional Chinese medicines. In particular, the traditional Chinese medicine for treating vitiligo is prepared from the following Chinese medicinal raw materials in parts by weight: 9-18 parts of trichosanthes palmate, 9-18 parts of tribulusterrestris, 9-18 parts of mulberry fruit, 9-18 parts of lithospermum, 6-12 parts of fructus cnidii, 6-12 parts of glossy privet fruit, 6-10 parts of radices sileris, 2-6 parts of moutan bark, 2-6 parts of radix clematidis and 1-5 parts of borneol. The invention aims at achieving the technical effects that the external preparation for treating vitiligo is good in treatment effect on vitiligo, high in effective rate, short in treatment course and low in price.

Description

A kind of external preparation for the treatment of vitiligo
Technical field
The present invention relates to a kind of Chinese medicine compound, be specifically related to one and treat leukodermic external preparation and preparation method thereof.
Background technology
Vitiligo is a kind of agnogenic depigmentation dermatoses, though without sufferings, multiple at human body exsertion part, and the large stretch of white macula particularly in head, face, neck, item, wrist, for fear of appearance, can bring heavy mental burden to people.
Traditional Chinese medical science medical science is referred to as " vitiligo " or " vitiligo ".Chinese medicine is thought, leukodermic Etiological pathogenesis is stagnation of QI due to depression of the liver, deficiency of the liver and kindey, stagnation of QI-blood.Exopathogen is taken advantage of a weak point in opponent's defence and is attacked, and visitor enters flesh table, and meridians are obstructed, coagulation of QI-blood, and fur space between skin and muscles loses supports and the speckle that turns white.12 meridians, eight extra-channel all can be invaded by pathogenic factor, and all can fall ill in any position of body surface, have bilateral symmetric property characteristics of incidence, the how double congestion of course of disease elder.Lung governing qi, at body and skin, its Hua Mao.Have Xuan Fawei gas, semen deposition is in physiological functions such as furs.Chinese traditional treatment pathogensis of vitiligo vulgaris many employings tonifying liver lung kidney, regulate the flow of vital energy and blood, invigorating striae of the skin method for the treatment of.
Current doctor trained in Western medicine has following several to vitiligo method: 1. Drug therapy.Psoralen and derivatives for treatment thereof: such as add ultraviolet radiation as methoxsalen is oral.Megavitamin is treated, and such as vitamin B complex, vitamin C, Citrin long-term, high-dose are taken.The treatment such as the medicine of useful cupric is as oral in 0.5% copper-bath.Immunomodulator is treated, and such as levamisole is oral, lyophilized bacillus calmette-guerin vaccine (BCG) intramuscular injection, oral Bovine Placenta etc.Treatment is embrocated in skin irritant local makes skin be inflamed reaction, and impel pigment hypertrophy, dust head has 30% psoralea tincture, chlormethine ethanol, phenol (pure carbolic acid), 25% ~ 50% trichloroacetic acid, Mylabris tincture etc.This method is only applicable to small pieces skin lesion, and after being coated with, skin lesion place can occur bulla.Corticosteroid treatment, various corticosteroid hormone is as local package treatments such as propanoic acid beclometasone ointment, halometasone cream, omcilon carbamide ointments, and this method side effect is very large.2. operative treatment.AUTOEPIDERMIC GRAFTING is performed the operation.3. decolouring therapy.Be applicable to skin lesion area large, exceed body surface area person over half, put on the skin outside available 3% ~ 20% hydroquinone list methyl phenyl ethers anisole frost.4. physiotherapy, adopts narrow ripple ultraviolet, long wave ultraviolet or 308nm excimer laser treatment.
Chinese traditional treatment medicine mainly contains: the painted soup of Lignum Sappan, TONGQIAOHUOXUE Decoction, YIN nourishing Tongluo Decoction, refrigerant yin-nourishing soup, Fructus Tribuli Lagerstroemia indica L. soup, Radix Bupleuri resolving depression soup, compound recipe SIWU TANG etc. tens of kinds.
Summary of the invention
Technical problem to be solved by this invention is to provide a kind of good to vitiligo therapeutic effect, and effective percentage is high, short treating period, the leukodermic Chinese medicine composition of cheap treatment.
The present invention mainly adopts following technical scheme to realize:
One treats leukodermic external preparation, is made up of following raw material of Chinese medicine:
Radix Stephaniae Cepharanthae, Fructus Atriplicis Sibiricae, Fructus Mori, Radix Arnebiae (Radix Lithospermi), Fructus Cnidii, Fructus Ligustri Lucidi, Radix Saposhnikoviae, Cortex Moutan, Radix Clematidis, Borneolum Syntheticum.
As preferably, the present invention treats leukodermic Chinese medicine composition, is made up of the raw material of Chinese medicine of following parts by weight:
Radix Stephaniae Cepharanthae 9-18, Fructus Atriplicis Sibiricae 9-18, Fructus Mori 9-18, Radix Arnebiae (Radix Lithospermi) 9-18, Fructus Cnidii 6-12, Fructus Ligustri Lucidi 6-12, Radix Saposhnikoviae 6-10, Cortex Moutan 2-6, Radix Clematidis 2-6, Borneolum Syntheticum 1-5.
As preferably, the present invention treats leukodermic external preparation, is made up of the raw material of Chinese medicine of following parts by weight:
Radix Stephaniae Cepharanthae 16, Fructus Atriplicis Sibiricae 16, Fructus Mori 12, Radix Arnebiae (Radix Lithospermi) 12, Fructus Cnidii 8, Fructus Ligustri Lucidi 8, Radix Saposhnikoviae 6, Cortex Moutan 3, Radix Clematidis 3, Borneolum Syntheticum 2.
External preparation of the present invention can add appropriate adjuvant as required, such as antiseptic, dispersant, suspending agent, thickening agent, cosolvent, wetting agent, buffer agent, emulsifying agent, stabilizing agent, transdermal enhancer etc.
As preferably, external preparation of the present invention is preferably ointment, gel or liniment.
Present invention also offers a kind of preparation method for the treatment of Leukoderma liniment, it is characterized in that comprising the following steps:
1) take above-mentioned each raw material, after grinder grinding, cross 100 mesh sieves, by weight portion mix homogeneously of the present invention, add the vegetable oil of 2-4 times amount, stir 1-3 hour, under room temperature, soak 7-14 days, filter, filtrate is for subsequent use;
2) in filtering residue, add the vegetable oil of 2-4 amount again, be heated to 100-130 degree Celsius, insulated and stirred 2-4 hour, filter, by for subsequent use near for filtrate room temperature;
3) merging filtrate, sterilizing, subpackage, obtains Chinese medicine composition composition liniment of the present invention.
Preferably, the vegetable oil described in above-mentioned preparation method is selected from one or more in Oleum sesami, Castor oil, soybean oil, Oleum Arachidis hypogaeae semen, olive oil.
Preferably, the vegetable oil described in above-mentioned preparation method most preferably is Oleum sesami.
It will be appreciated by persons skilled in the art that the present invention also according to existing Chinese medicine extraction technology, can be prepared into other external preparation.
In side of the present invention, the efficiency analysis of medical material used is as follows: Radix Stephaniae Cepharanthae: bitter, cold.Heat-clearing and toxic substances removing, cooling blood for hemostasis, pain relieving.Fructus Atriplicis Sibiricae: pungent, bitter, tepor; Slightly poisonous.Suppressing the hyperactive liver resolving depression, promoting blood circulation by removing wind, improving eyesight, antipruritic.Dizzy for having a headache, distending pain in the chest and hypochondrium, breast closes acute mastitis, cataract, rubella pruritus.Fructus Mori: sweet; Acid; Cold in nature, nourishing YIN and benefiting blood; Promote the production of body fluid; Intestine moistening, having a dizzy spell of main deficiency of the liver and kindey and blood deficiency damage of essence; Soreness of waist tinnitus; Early whitening of beard and hair; Insomnia and dreamful sleep; Tianjin wound is thirsty; Quench one's thirst; Dryness of the intestine constipation.Radix Arnebiae (Radix Lithospermi): sweet, salty, cold.Removing heat from blood, invigorates blood circulation, removing toxic substances rash.Contain for heat in blood poison, macule purple is black, measles without adequate eruption, skin infection, eczema, burn due to hot liquid or fire.Fructus Cnidii: pungent, bitter, temperature; Slightly poisonous.Warming the kidney to invigorate YANG, dampness, dispels the wind, parasite killing.Fructus Ligustri Lucidi: sweet, bitter, cold.Nourishing the liver and kidney, improving eyesight black hair.For vertigo and tinnitus, soreness of the waist and knees, early whitening of beard and hair, poor vision.Radix Saposhnikoviae: acrid, sweet, warm.Inducing diaphoresis to dispel wind, victory is wet, relieving convulsion.For headache due to common cold, rheumatic arthralgia, rubella pruritus, tetanus.Cortex Moutan: bitter, pungent, is slightly cold.Clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.For maculae caused by violent heat pathogen, hematemesis and epistaxis, night fever abating at dawn, lossless hectic fever due to YIN-deficiency, amenorrhea dysmenorrhea, carbuncle sore tumefacting virus, falls and flutters the pain of injury.Radix Clematidis: pungent, salty, temperature.Expelling wind and removing dampness, removing obstruction in the collateral to relieve pain.For rheumatic arthralgia, numb limbs and tense tendons, the contracture of muscle arteries and veins, joint stuffiness, bone is choked with sobs larynx.Borneolum Syntheticum: pungent, bitter, is slightly cold.To have one's ideas straightened out refreshment, clearing away heat to alleviate pain.
The present invention treats leukodermic external preparation usage and dosage: smear affected part every day 3 times, and the morning, noon and afternoon, respectively once, after smearing, available preservative film covered, and effect more.30 days courses for the treatment of.Pungent, greasy and seafood is avoided during medication.
The present invention treats leukodermic external preparation, and preparation method is simple, and cost is low, and cure rate is high, short treating period, and crude drug source is extensive, and safe without toxic side effect, is applicable to promoting the use of.
Detailed description of the invention
Embodiment 1
The preparation of liniment of the present invention:
Prescription:
Radix Stephaniae Cepharanthae 16kg Fructus Atriplicis Sibiricae 16kg Fructus Mori 12kg Radix Arnebiae (Radix Lithospermi) 12kg Fructus Cnidii 8kg
Fructus Ligustri Lucidi 8kg Radix Saposhnikoviae 6kg Cortex Moutan 3 kg Radix Clematidis 3kg Borneolum Syntheticum 2kg
Preparation technology:
1) by above-mentioned prescription, take each raw material, after grinder grinding, cross 100 mesh sieves, mix homogeneously, adds the vegetable oil of 3 times amount, stirs 2 hours, soaks 7 days under room temperature, filters, obtains filtrate;
2) in filtering residue, add the Oleum sesami of 2 times amount, be heated to 105-110 degree Celsius, insulated and stirred 2 hours, filter, obtain filtrate;
3) merging filtrate, sterilizing, subpackage, obtains Chinese medicine composition composition liniment of the present invention.
Embodiment 2
The preparation of liniment of the present invention:
Prescription:
Radix Stephaniae Cepharanthae 18kg Fructus Atriplicis Sibiricae 18kg Fructus Mori 18kg Radix Arnebiae (Radix Lithospermi) 9kg Fructus Cnidii 6kg
Fructus Ligustri Lucidi 6kg Radix Saposhnikoviae 8kg Cortex Moutan 4kg Radix Clematidis 3kg Borneolum Syntheticum 3kg
Preparation technology:
1) by above-mentioned prescription, take each raw material, after grinder grinding, cross 100 mesh sieves, mix homogeneously, adds the vegetable oil of 3 times amount, stirs 2 hours, soaks 14 days under room temperature, filters, obtains filtrate;
2) in filtering residue, add the Oleum sesami of 3 times amount, be heated to 100-105 degree Celsius, insulated and stirred 2 hours, filter, obtain filtrate;
3) merging filtrate, sterilizing, subpackage, obtains Chinese medicine composition composition liniment of the present invention.
Embodiment 3
The preparation of liniment of the present invention:
Prescription:
Radix Stephaniae Cepharanthae 12kg Fructus Atriplicis Sibiricae 12kg Fructus Mori 12kg Radix Arnebiae (Radix Lithospermi) 18kg Fructus Cnidii 12kg
Fructus Ligustri Lucidi 12kg Radix Saposhnikoviae 6kg Cortex Moutan 2kg Radix Clematidis 6kg Borneolum Syntheticum 1kg
Preparation technology:
1) by above-mentioned prescription, take each raw material, after grinder grinding, cross 100 mesh sieves, mix homogeneously, adds the vegetable oil of 3 times amount, stirs 2 hours, soaks 14 days under room temperature, filters, obtains filtrate;
2) in filtering residue, add the Oleum sesami of 3 times amount, be heated to 100-105 degree Celsius, insulated and stirred 2 hours, filter, obtain filtrate;
3) merging filtrate, sterilizing, subpackage, obtains Chinese medicine composition composition liniment of the present invention.
Above embodiment is not restriction the present invention being made to other form, and the equivalence that any those skilled in the art may utilize the technology contents of above-mentioned announcement to be changed or be modified as equivalent variations is implemented.But everyly do not depart from technical solution of the present invention content, any simple modification, equivalent variations and the remodeling done above embodiment according to technical spirit of the present invention, still belong to the protection domain of technical solution of the present invention.
Clinical efficacy criterion and therapeutic outcome:
1, clinical data and diagnostic criteria
Clinical data: the present inventor in 2009 so far, carries out clinical observation treatment to 218 routine patients with vitiligo, wherein man 160 example, female 58 example, max age 56 years old, minimal ages 11 years old, 23.6 years old mean age.The course of disease is the shortest is 2 months, and the longest is 15 years.
Diagnostic criteria: speckle or the patch of the white of depigmentation appear in skin surface.Around normal skin.Decolouring speckle differs in size from several millimeters to several centimetres, and in progressive stage, skin lesion can expand gradually, and constantly has new decolouring speckle to occur.The patient that the colour of skin is more shallow, white macula can be not obvious, but dark-complexioned people, color contrast is then very distinct.Under wood lamp, vitiligo position and surrounding skin have obviously boundary.
2, Therapeutic Method
In affected part, every day smears the obtained liniment of the embodiment of the present invention 13 times, and the morning, noon and afternoon, respectively once 30 days courses for the treatment of, 2 courses for the treatment of were a treatment cycle.Pungent, greasy and seafood is avoided during medication.
3, curative effect judging standard:
Cure: white macula all disappears, recover normal skin tone;
Effective: white macula partial remission or reduce, recover normal skin tone, disappear or reduce that area accounts for skin lesion area more than 50%.
Effective: white macula partial remission or reduce;
Invalid: the regeneration of white macula non-pigment or expanded range.
4, therapeutic outcome:
After the treatment through 2 courses for the treatment of, cure 140 examples, cure rate is 64.2%; Effective 44 examples, obvious effective rate 20.2%; Effective 26 examples, effective percentage 11.9%; Invalid 8 examples; Total effective rate 96.3%.
Model case
1, poplar, man, 16 years old, suffer from vitiligo 2 years, face, the back of the hand, arm many places have vitiligo speckle, white macula sharpness of border.In February, 2012, carry out here treatment, after adopting 2 courses for the treatment of of medicine of the present invention, white macula all disappears, and normal skin tone is recovered at speckle place, continuing to strengthen 1 course for the treatment of of use, following up a case by regular visits to without recurring after 2 years.
2, season, female, 18 years old, suffer from vitiligo 6 months, there are white macula 2 square centimeters of irregular type vitiligo in cervical region position, white macula sharpness of border, in June, 2012, carry out here treatment, after adopting 2 courses for the treatment of of medicine of the present invention, white macula all disappears, and normal skin tone is recovered at speckle place, continue to strengthen 1 course for the treatment of of use, follow up a case by regular visits to after 2 years without recurrence.
3, Xing, man, 43 years old, suffer from vitiligo 4 years, facial, front abdomen, the back of the hand, the whole province's multiple locations such as upper limb, lower limb, biped all had the vitiligo speckle of different size, white macula sharpness of border.In April, 2013, carry out here treatment, after adopting 2 courses for the treatment of of medicine of the present invention, white macula all disappears, and normal skin tone is recovered at speckle place, continuing to strengthen 1 course for the treatment of of use, following up a case by regular visits to without recurring after 1 year.
4, Lee, female, 25 years old, suffer from vitiligo 6 years, face, the back of the hand, all there is the vitiligo speckle of different size at back, white macula sharpness of border.Once AUTOEPIDERMIC GRAFTING operation was done, poor effect.In June, 2013, carry out here treatment, after adopting 2 courses for the treatment of of medicine of the present invention, white macula all disappears, and normal skin tone is recovered at speckle place, continuing to strengthen 1 course for the treatment of of use, following up a case by regular visits to without recurring after 1 year.
5, season, man, 36 years old, suffer from vitiligo 4 years, face, the back of the hand, the healths such as the palm of the hand, back, leg all have the vitiligo speckle of different size, white macula sharpness of border.Once the AUTOEPIDERMIC GRAFTING operation of face was done, poor effect.In August, 2013, carry out here treatment, after adopting 2 courses for the treatment of of medicine of the present invention, white macula all disappears, and normal skin tone is recovered at speckle place, continuing to strengthen 1 course for the treatment of of use, following up a case by regular visits to without recurring after 1 year.

Claims (9)

1. treat a leukodermic external preparation, it is characterized in that, be made up of following raw material of Chinese medicine: Radix Stephaniae Cepharanthae, Fructus Atriplicis Sibiricae, mulberry, Radix Arnebiae (Radix Lithospermi), Fructus Cnidii, Fructus Ligustri Lucidi, Radix Saposhnikoviae, Cortex Moutan, Radix Clematidis, Borneolum Syntheticum.
2. treat a leukodermic external preparation, it is characterized in that, be made up of the raw material of Chinese medicine of following parts by weight:
Radix Stephaniae Cepharanthae 9-18, Fructus Atriplicis Sibiricae 9-18, Fructus Mori 9-18, Radix Arnebiae (Radix Lithospermi) 9-18, Fructus Cnidii 6-12, Fructus Ligustri Lucidi 6-12, Radix Saposhnikoviae 6-10, Cortex Moutan 2-6, Radix Clematidis 2-6, Borneolum Syntheticum 1-5.
3. treat a leukodermic external preparation, it is characterized in that, be made up of the raw material of Chinese medicine of following parts by weight:
Radix Stephaniae Cepharanthae 16, Fructus Atriplicis Sibiricae 16, Fructus Mori 12, Radix Arnebiae (Radix Lithospermi) 12, Fructus Cnidii 8, Fructus Ligustri Lucidi 8, Radix Saposhnikoviae 6, Cortex Moutan 3, Radix Clematidis 3, Borneolum Syntheticum 2.
4. the leukodermic external preparation for the treatment of as described in as arbitrary in claim 1-3, it is characterized in that, can also add pharmaceutically conventional adjuvant, described adjuvant is including but not limited to antiseptic, dispersant, suspending agent, thickening agent, cosolvent, wetting agent, buffer agent, emulsifying agent, stabilizing agent, transdermal enhancer.
5. the leukodermic external preparation for the treatment of as described in as arbitrary in claim 1-3, it is characterized in that, described external preparation is preferably ointment, gel or liniment.
6. the leukodermic external preparation for the treatment of as claimed in claim 5, it is characterized in that, described external preparation is liniment.
7. the leukodermic external preparation for the treatment of as claimed in claim 6, it is characterized in that, the preparation method of described liniment comprises the following steps:
1) take above-mentioned each raw material, after grinder grinding, cross 100 mesh sieves, by weight portion mix homogeneously of the present invention, add the vegetable oil of 2-4 times amount, stir 1-3 hour, under room temperature, soak 7-14 days, filter, filtrate is for subsequent use;
2) in filtering residue, add the vegetable oil of 2-4 amount again, be heated to 100-130 degree Celsius, insulated and stirred 2-4 hour, filter, by for subsequent use near for filtrate room temperature;
3) merging filtrate, sterilizing, subpackage, obtains Chinese medicine composition composition liniment of the present invention.
8. the leukodermic external preparation for the treatment of as claimed in claim 7, is characterized in that, step 1) and step 2) vegetable oil in described preparation method be selected from Oleum sesami, Castor oil, soybean oil, Oleum Arachidis hypogaeae semen, olive oil one or more.
9. the leukodermic external preparation for the treatment of as claimed in claim 8, is characterized in that, step 1) and step 2) vegetable oil in described preparation method is Oleum sesami.
CN201410504899.0A 2014-09-27 2014-09-27 External preparation for treating vitiligo Pending CN104257781A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410504899.0A CN104257781A (en) 2014-09-27 2014-09-27 External preparation for treating vitiligo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410504899.0A CN104257781A (en) 2014-09-27 2014-09-27 External preparation for treating vitiligo

Publications (1)

Publication Number Publication Date
CN104257781A true CN104257781A (en) 2015-01-07

Family

ID=52149438

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410504899.0A Pending CN104257781A (en) 2014-09-27 2014-09-27 External preparation for treating vitiligo

Country Status (1)

Country Link
CN (1) CN104257781A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108619329A (en) * 2018-07-25 2018-10-09 王益元 A kind of Chinese medicinal ointment and preparation method thereof for treating leucoderma

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185970A (en) * 1998-01-06 1998-07-01 宋守金 External use medicine for vitiligo
CN101028375A (en) * 2007-04-04 2007-09-05 孙立新 Oral externally-applied Chinese medicinal composition for treating leucoderma
CN101433606A (en) * 2008-11-20 2009-05-20 王洪斌 External-use agent for treating vitiligo

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1185970A (en) * 1998-01-06 1998-07-01 宋守金 External use medicine for vitiligo
CN101028375A (en) * 2007-04-04 2007-09-05 孙立新 Oral externally-applied Chinese medicinal composition for treating leucoderma
CN101433606A (en) * 2008-11-20 2009-05-20 王洪斌 External-use agent for treating vitiligo

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
张春艳、许爱娥: "治疗白癜风的中药外用制剂总结分析", 《中华中医药学刊》, vol. 30, no. 9, 30 September 2012 (2012-09-30), pages 2074 - 2077 *
钟佳乐、刁庆春: "外用中药治疗白癜风研究进展", 《光明中医》, vol. 29, no. 5, 31 May 2014 (2014-05-31), pages 1125 - 1127 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108619329A (en) * 2018-07-25 2018-10-09 王益元 A kind of Chinese medicinal ointment and preparation method thereof for treating leucoderma

Similar Documents

Publication Publication Date Title
CN102988657A (en) Plaster for treating fracture and traumatic injury and preparation method of plaster
CN104352811A (en) Plaster for curing bone injury and preparation method thereof
CN107296945A (en) A kind of Chinese medicine composition and its processing method for thunder gunpowder moxibustion
CN104257781A (en) External preparation for treating vitiligo
CN103623247A (en) Medicine for treating dizziness
CN103394042A (en) Traditional Chinese medicine tincture used for adjuvant therapy on bone fracture
CN102641365B (en) Special external-use compound preparation for treating burns, scalding and various traumas
CN110038101A (en) A kind of Chinese medicine is dispelled antipruritic external preparation of pain and preparation method thereof
CN105641282B (en) External traditional Chinese medicine composition for treating neck, shoulder, waist and leg pain
CN104107366A (en) Applying ointment used for treating tinea and preparation method thereof
CN103877557B (en) A kind of Chinese medicine ointment and preparation method for the treatment of tinea unguium
CN103239536B (en) Traditional Chinese medicine for treating influenza and preparation method thereof
CN103127349B (en) Medicine for treating traumatic injury
CN102451249B (en) Drug for treating burn and scald, and application thereof
CN101357153B (en) No-scar medicine for treating burn and scald and preparation method thereof
CN106955314A (en) Heat-clearing river Huang of invigorating blood circulation dissipates
CN106728069A (en) It is a kind of to treat the putrefaction-removing granulation-promoting paste for scalding burn
CN108465006B (en) Composition and plaster for treating knee osteoarthritis
CN104644868A (en) Traditional Chinese medicine composition for treating arthritis caused by rheumatic fever and preparation method of traditional Chinese medicine composition
CN104383057A (en) Paste for mainly treating traumatic injury and preparation method of paste for mainly treating traumatic injury
CN105582243A (en) Traditional Chinese medicine composition for treating solar dermatitis
CN105250533A (en) Traditional Chinese medicine patch for treating postpartum blood stasis and preparation method thereof
CN104888195A (en) Plant essence peptide composition for promoting wound healing
CN104257931A (en) Orthopedic traumatic injury external application patch and preparation method thereof
CN103610869A (en) Burn cream and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150107